Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
Applications | IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
Applications | ELISA, IF, IHC, IP, WB |
Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
Applications | ELISA, FC, IF, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
USD 523.00
2 Weeks
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | FC, IF, IHC, WB |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | ELISA, FC, IF, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
Applications | ELISA, IF |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Conjugation | Unconjugated |